Theravance Biopharma (TBPH) Tax Provisions (2014 - 2026)
Theravance Biopharma's Tax Provisions came in at $1.11 million for Q2 2026, down 94.0% from $18.37 million a year earlier.
Powered by 
Analysis
Theravance Biopharma (TBPH) Tax Provisions (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Theravance Biopharma reported Tax Provisions of $5.16 million, down 80.9% year-over-year; for FY2025, it was $23.4 million, up 98.2% from FY2024.
- Going back by year, Tax Provisions was $11.8 million in FY2024 (+99.3%), $5.92 million in FY2023, $9,000 in FY2022 and -$200,000 in FY2021.
- The five-year range for quarterly Tax Provisions is -$6.5 million (Q3 2025) to $18.37 million (Q2 2025).
- Year-over-year, Tax Provisions increased in three of the last four quarters, with growth averaging 42.9%.
- Business Quant data shows TBPH's Tax Provisions at -$1.54 million (Q1 2026), $12.09 million (Q4 2025) and -$6.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | -1.54 Mn |
| Dec 31, 2025 | 12.09 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Jun 30, 2025 | 18.37 Mn |
| Mar 31, 2025 | -559,000.00 |
| Dec 31, 2024 | 6.59 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | -395,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -507,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 524,000.00 |
| Dec 31, 2021 | -200,000.00 |
| Sep 30, 2021 | -7,000.00 |
API Access
Theravance Biopharma Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();